Lumexa Imaging Holdings IncLMRI
Price$10.10

Outlook & Key Dates

Estimates, guidance, catalysts, and upcoming events

Analyst Estimates Learn more →
Analyst Coverage
7analysts covering
Consensus: PositiveAs of 18 Aug 2026
FY Revenue (est.)
$1.1Bnext fiscal year
As of 18 Aug 2026
FY EPS (est.)
$0.77next fiscal year
As of 18 Aug 2026
Monitoring Framework
Key Performance Indicators
Consolidated Revenues Quarterly252.5MTarget: 1.045 billion to 1.097 billion
Adjusted EBITDA Quarterly51.2MTarget: 234 million to 242 million
Same Center Advanced Volume Growth Quarterly560.0%
Advanced Modalities Mix of Total Volume Quarterly37.4

Research as of 20 Jun 2026

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.